Skip to content

Author

Chun-Lei Hu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Efficacy and toxicities of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for unresectable pancreatic cancer: a systematic review and meta-analysis

Objective Modified FOLFIRINOX (mFFX) and gemcitabine plus nab-paclitaxel (GnP) are both recommended as standard first-line regimens for unresectable pancreatic cancer (PC). However, direct head-to-head comparative evidence remains scarce, and prior studies have largely failed to distinguish mFFX from standard FOLFIRINO...

Chun-Lei Hu, Li Zhan, Yan-Hui Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.